Menu
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • MRI Phantoms
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
  • FAST Login
  • Easy Setup
  • Find a Centre
  • SMART Portal
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • MRI Phantoms
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
Home | Investors | ASX Announcements | 2019

ASX Announcements 2019

Date Document
03/12/2019 Change of Director's Interest Notice x 4
03/12/2019 Appendix 3B and Secondary Trading Notice
28/11/2019 Results of Meeting
28/11/2019 Resonance Health Partners with Siemens healthineers
25/11/2019 Investor Presentation November 2019
21/11/2019 New AI Tool for Automated Assessment of Liver Fat
20/11/2019 Resonance Health Files Provisional Patent
28/10/2019 Appendix 4C - quarterly
25/10/2019 Notice of Annual General Meeting/Proxy Form
22/10/2019 Updated Securities Trading Policy
22/10/2019 Annual Report to shareholders
22/10/2019 Appendix 4G and Corporate Governance Statement
27/09/2019 Full Year Statutory Accounts
27/08/2019 Preliminary Final Report
29/07/2019 Appendix 4C - quarterly
19/07/2019 Resonance Health contracted new clinical trials
16/07/2019 Appendix 3B and Secondary Trading Notice
01/05/2019 Secondary Trading Notice
30/04/2019 R&D Activities Update and Appendix 3B
16/04/2019 Customer Newsletter - April 2019
16/04/2019 Appendix 4C - quarterly
15/04/2019 Response to ASX Price and Volume Query
25/03/2019 Investor Presentation March 2019
25/02/2019 Half Yearly Report and Accounts
05/02/2019 Change of Director's Interest Notice
21/01/2019 Appendix 4C - quarterly
15/01/2019 Execution of Distribution Agreement with EnvoyAI
03/01/2019 Execution of License Agreement

Investors

  • Business Overview
  • Board and Management Team
  • Share Price
  • ASX Announcements
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
  • ASX subscribe
  • Annual Reports
  • Analyst Coverage
  • Twitter
  • LinkedIn
  • Search
  • © 2018 Resonance Health
  • Disclaimer
  • Privacy
  • Sitemap
Website by ChooseDigital.com.au